Document is current
Any future updates will be listed below
-
Authors
Bentivenga, Giuseppe Mario
Mammana, Angela
Gogishvili, Dea
Baiardi, Simone
Vittoriosi, Erica
Mastrangelo, Andrea
Ranieri, Agustina
Houtkamp, Isabel M.
Brockmann, Kathrin
Abeln, Sanne
Capellari, Sabina
Parchi, Piero
-
Funding
Funding for this research was provided by:
EU Joint Programme – Neurodegenerative Disease Research (01ED2407A)
EU Joint Programme – Neurodegenerative Disease Research (01ED2407A)
EU Joint Programme – Neurodegenerative Disease Research (01ED2407A)
EU Joint Programme – Neurodegenerative Disease Research (01ED2407A)
Ministero della Salute (Ricerca corrente)
Ministero dell'Università e della Ricerca (MNESYS (PE0000006))
- License Information
-
More Information
Article History
Received: 9 June 2025
Accepted: 20 October 2025
First Online: 15 December 2025
Declarations
:
: The study was conducted according to the revised Declaration of Helsinki and Good Clinical Practice guidelines and approved by the local ethics committee (approval number AVEC:18025, 113/2018/OSS/AUSLBO). Written informed consent was given by study participants or the next of kin.
: Not applicable.
: GMB, AM (Angela Mammana), DG, SB, EV, AM (Andrea Mastrangelo), AR, IMH, KB, SC, and PP declare no competing interests. Outside the submitted work: SA reports a patent pending; SA is in a consortium agreement with Cergentis BV as part of the TargetSV project; SA is in a consortium agreement with Olink and Quanterix as part of the NORMAL project.
